(Hypertension. 2001;37:129.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
Role of Cyclooxygenase-2–Derived Metabolites and NO in Renal Response to Bradykinin
From the Departamento de Fisiología, Facultad de Medicina, Murcia, Spain.
Correspondence to F. Javier Salazar, Departamento de Fisiología, Facultad de Medicina, 30100 Murcia, Spain. E-mail salazar{at}um.es
Abstract—It has been reported that bradykinin (BK) can induce or activate both cyclooxygenase (COX) isoforms and that the renal effects of BK seem to be mediated by prostaglandins and NO. The first objective of this study was to evaluate the relative contribution of both COX isoforms in mediating the renal response to BK in anesthetized dogs. The second objective was to examine whether COX-2 inhibition potentiates the renal effects induced by NO reduction during BK administration. Intrarenal BK infusion (8 ng · kg-1 · min-1, n=6) elicited a significant increment in renal blood flow, sodium excretion, urine volume, and the fractional excretion of lithium. COX-2 inhibition (nimesulide, 5 µg · kg-1 · min-1, n=6) reduced the renal vasodilatation but did not significantly modify the natriuresis or diuresis secondary to BK. Administration of a nonspecific isozyme COX inhibitor (meclofenamate, 5 µg · kg-1 · min-1; n=6) did not induce greater effects than those produced by nimesulide. NO synthesis reduction (NG-nitro-L-arginine methyl ester [L-NAME], 3 µg · kg-1 · min-1) prevented the renal vasodilatation and the increment in the fractional excretion of lithium induced by BK but did not affect the natriuretic or diuretic response. Simultaneous nimesulide infusion did not modify the renal effects of L-NAME during BK infusion (n=6). Finally, inhibition of both COX isoforms with meclofenamate, in dogs treated with L-NAME (n=6), completely prevented the vasodilator and excretory actions of BK. The results of this study suggest that (1) NO and prostanoids dependent on COX-2 seem to be involved in the renal vasodilatation induced by BK, and (2) there is an interaction between NO and COX-1–derived metabolites in mediating the natriuretic and diuretic response to BK.
Key Words: hemodynamics • natriuresis • prostaglandins • cyclooxygenase • nitric oxide • bradykinin
This article has been cited by other articles:
 |
|
 |
|
  J. A. Rodriguez, C. P. Vio, P. L. Pedraza, J. C. McGiff, and N. R. Ferreri Bradykinin Regulates Cyclooxygenase-2 in Rat Renal Thick Ascending Limb Cells Hypertension, August 1, 2004; 44(2): 230 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Campean, F. Theilig, A. Paliege, M. Breyer, and S. Bachmann Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse) Am J Physiol Renal Physiol, July 1, 2003; 285(1): F19 - F32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lopez, M. T. Llinas, F. Roig, and F. J. Salazar Role of nitric oxide and cyclooxygenase-2 in regulating the renal hemodynamic response to norepinephrine Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R488 - R493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Roig, M. T. Llinas, R. Lopez, and F. J. Salazar Role of Cyclooxygenase-2 in the Prolonged Regulation of Renal Function Hypertension, November 1, 2002; 40(5): 721 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Llinas, R. Lopez, F. Rodriguez, F. Roig, and F. J. Salazar Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine Am J Physiol Renal Physiol, November 1, 2001; 281(5): F975 - F982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Leon, J. Marchetti, and C. P. Vio Renal Cyclooxygenase-2: Evidence for Recruitment of Thick Ascending Limb of Henle Cells in Microdissected Nephron Segments Hypertension, September 1, 2001; 38(3): 630 - 634. [Abstract] [Full Text] [PDF]
|
|